Cargando…

Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers

Intranasal delivery of drugs offers several potential benefits related to ease of delivery, rapid onset, and patient experience, which may be of particular relevance to patients with central nervous system (CNS) conditions who experience acute events. Intranasal formulations must be adapted to addre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madden, Stuart, Carrazana, Enrique, Rabinowicz, Adrian L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458890/ https://www.ncbi.nlm.nih.gov/pubmed/37631332 http://dx.doi.org/10.3390/pharmaceutics15082119

Ejemplares similares

Improvement of Intranasal Drug Delivery with Intravail(®) Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
por: Rabinowicz, Adrian L., et al.
Publicado: (2021)

Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters
por: Cloyd, James, et al.
Publicado: (2021)

The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters
por: Chung, Steve, et al.
Publicado: (2022)

Use of intranasal rescue therapy for seizure clusters in students with epilepsy: Nurses’ knowledge, perceptions, and practice
por: Santilli, Nancy, et al.
Publicado: (2023)

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers
por: Tanimoto, Sarina, et al.
Publicado: (2020)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
por: Crowe, Tyler P., et al.
Publicado: (2022)

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

Clarification of Dalfampridine Labeled Indications
por: Rabinowicz, Adrian L., et al.
Publicado: (2012)

Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system
por: McGowan, Jeremy WD, et al.
Publicado: (2016)

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
por: Pandey, Manisha, et al.
Publicado: (2022)

Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications
por: Rabinowicz, Adrian L, et al.
Publicado: (2022)

Establishment of an Olfactory Region-specific Intranasal Delivery Technique in Mice to Target the Central Nervous System
por: Flamm, Johannes, et al.
Publicado: (2022)

Intranasal Treatment of Central Nervous System Dysfunction in Humans
por: Chapman, Colin D., et al.
Publicado: (2012)

Strategies for Enhanced Drug Delivery to the Central Nervous System
por: Dwibhashyam, V. S. N. M., et al.
Publicado: (2008)

Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method
por: Klitgaard, Mette, et al.
Publicado: (2021)

Central nervous system uptake of intranasal glutathione in Parkinson’s disease
por: Mischley, Laurie K, et al.
Publicado: (2016)

Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis
por: Cascino, Gregory D., et al.
Publicado: (2022)

Recent Patents on Permeation Enhancers for Drug Delivery Through Nails
por: Kreutz, Tainá, et al.
Publicado: (2019)

Nanomaterials for Drug Delivery to the Central Nervous System
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)

Hydrogel increases diclofenac skin permeation and absorption
por: Haltner‐Ukomadu, Eleonore, et al.
Publicado: (2019)

Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation
por: Rajan, Reshmy, et al.
Publicado: (2011)

Ionic Liquids as Potential and Synergistic Permeation Enhancers for Transdermal Drug Delivery
por: Sidat, Zainul, et al.
Publicado: (2019)

Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches
por: Hmingthansanga, Victor, et al.
Publicado: (2022)

Utilization of Sodium Nitroprusside as an Intestinal Permeation Enhancer for Lipophilic Drug Absorption Improvement in the Rat Proximal Intestine
por: Kishimoto, Hisanao, et al.
Publicado: (2021)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis
por: Wu, Haiyang, et al.
Publicado: (2021)

Liposomal Conjugates for Drug Delivery to the Central Nervous System
por: Helm, Frieder, et al.
Publicado: (2015)

Pathogen-inspired drug delivery to the central nervous system
por: McCall, Rebecca L, et al.
Publicado: (2014)

Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems
por: Bartos, Csilla, et al.
Publicado: (2018)

Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation
por: Freag, May S, et al.
Publicado: (2013)

The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System
por: Galeano, Carlos, et al.
Publicado: (2018)

Advances in intranasal application of stem cells in the treatment of central nervous system diseases
por: Zhang, Yu-Ting, et al.
Publicado: (2021)

Current Status of Amino Acid-Based Permeation Enhancers in Transdermal Drug Delivery
por: Pereira, Rui, et al.
Publicado: (2021)

A New Brain Drug Delivery Strategy: Focused Ultrasound-Enhanced Intranasal Drug Delivery
por: Chen, Hong, et al.
Publicado: (2014)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration
por: Soleimanizadeh, Arghavan, et al.
Publicado: (2021)

New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery
por: Li, Yaosheng, et al.
Publicado: (2022)

Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study
por: Tarquinio, Daniel, et al.
Publicado: (2023)

Treatment of Seizure Clusters in Epilepsy: A Narrative Review on Rescue Therapies
por: Becker, Danielle A., et al.
Publicado: (2023)

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
por: DeVos, Sarah L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_44qqscmar95tu0p723uh9d1s7e